News
Check out the latest news, insights and unique analysis brought to you by Stockhead's team of business journalists and industry experts on Imugene.
RELATED STOCKHEAD STORIES
Health & Biotech
ASX Health Stocks: Patrys says brain cancer drug is effective; HitIQ awarded Aussie patent
News
ASX Large Caps: Investors flock to metal stocks on BHP-OZL news; benchmark finishes flat
News
ASX Small Caps Lunch Wrap: Who else has learnt that it’s lonely at the top?
News
ASX Small Caps Lunch Wrap: Who else reckons sequels are always a bad idea?
Health & Biotech
Check Up: US FDA approves first clinical trial of naturally derived psychedelic drugs
News
ASX Small Caps Lunch Wrap: Who’s got someone coming round for lunch today?
Stockhead TV
V-Con: Small Cap Showcase – Companies set to perform and best bargains amidst turbulent market conditions
News
ASX Small Caps Lunch Wrap: Who else is hitting the creepy tech panic button today?
News
ASX Large Caps: All sectors in the green ahead of tomorrow’s rate hike
News
ASX Large Caps: Local shares flat, Aussie home prices accelerate descent
Health & Biotech
ScoPo’s Powerplays: ASX health stocks show signs of jittery recovery
News
ASX Small Caps Lunch Wrap: Who else is laughing at someone else’s expense today?
News
ASX Large Caps: Blue chips down for first time this week as Real Estate and Tech drag
News
ASX Small Caps Lunch Wrap: Who else is clutching their pearls today?
News
Closing Bell: ASX 200 rides the Wall Street wave, has its strongest lift in 6 weeks
News
ASX Large Caps: Banks, Miners, Tech pull blue chips back to the winner’s circle
News